Investigating the Influence of HPMC K4M and Eudragit L 100-55 on Guanfacine-Loaded Extended-Release Tablets

IF 1 4区医学 Q4 PHARMACOLOGY & PHARMACY

Dissolution Technologies Pub Date : 2023-01-01 DOI:10.14227/dt300123p22

Rakesh Patel, Himanshu Paliwal, A. Patel

引用次数: 0

Abstract

(Eudragit L100-55) were used as a hydrophilic matrix to prepare extended-release tablet formulations to release drug

查看原文本刊更多论文

考察HPMC K4M与乌龙茶l100 -55对胍法辛缓释片的影响

以乌龙茶L100-55为亲水性基质制备缓释片制剂

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Dissolution Technologies 医学-药学

CiteScore

1.20

自引率

33.30%

发文量

审稿时长

3 months

期刊介绍： Dissolution Technologies is a peer reviewed quarterly publication reporting ongoing, useful information on dissolution testing of pharmaceuticals. It provides an international forum for dissolution analysts to receive and exchange information on various dissolution topics. Dissolution Technologies welcomes submissions related to dissolution, in vitro release, and disintegration testing. These topics should be the major focus of the article. Do not submit articles where the focus is formulation development with dissolution testing as one of many tests.